close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Isotretinoin Triggers Bowel Disease

August 19, 2006

A suspected link between acne drug isotretinoin and inflammatory bowel disease has been confirmed by researchers.

Isotretinoin is sold in the US under the brand-name Accutane.

The report, by Deepa Reddy, MD, et al, was published in the American Journal of Gastroenterology and reported by Reuters on August 15.

Inflammatory bowel disease (IBD) includes Crohn’s disease and ulcerative colitis.

The Accutane Link

Since Accutane received US Food and Drug Administration (FDA) approval in 1982, several medical cases have suggested an association between it and IBD. However, until the study by Dr Reddy and colleagues, no one had conducted a systematic review of the link.

In this analysis, Dr Corey A Siegel, of Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, and colleagues reviewed all reports of IBD associated with isotretinoin that had been filed with the FDA through MedWatch, the FDA’s Safety Information and Adverse Event Reporting Program that began in 1996.

The researchers report using a standard adverse drug-reaction probability scale to gauge the likelihood of a particular IBD case being linked with isotretinoin use.

They reported that, between 1997 and 2002, doctors reported 85 isotretinoin-related cases of IBD. In four of these cases, isotretinoin was deemed a "highly probable" cause of the IBD; in 58 cases, it was seen as a "probable" cause; and in 23 cases it was viewed as a "possible" cause. In none of the cases was the link between IBD and isotretinoin graded "doubtful".

"Physicians and patients should be made aware of this possible association and it should be included in the already extensive consent process required before isotretinoin is prescribed," write the researchers.

The consent process for prescribing isotretinoin includes advice about the high risk of birth defects if a woman becomes pregnant while on isotretinoin, according to the Reuters article.

"We do not think that [the link with IBD] should prohibit the use of isotretinoin," Dr Siegel and colleagues write. However, they note that "careful consideration should be made" for people who have a personal or familial history of IBD, or people who have IBD-like symptoms.

Sources:
Acne med may trigger bowel disease, Reuters, August 15, 2006.
Possible Association Between Isotretinoin and Inflammatory Bowel Disease. Deepa Reddy et al, American Journal of Gastroenterology, volume 101, pages 1569–1573, July 2006.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...